ClinicalTrials.gg
RecruitingNCT07321340INORAUpdated Jun 5, 2026

Insole Optimization for Rheumatoid Arthritis Patients

An interventional study of gait analysis from 3D imaging (ENSENSO) in Rhumatoid Arthisis, sponsored by Centre Hospitalier Universitaire de Saint Etienne. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-05.

Sponsored by Centre Hospitalier Universitaire de Saint Etienne · Not applicable, Interventional, and Basic science

How we know

From the registry’s dates

  • Started Jun 2026; still recruiting 5 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
10
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 11 studies in Arthritis, Rheumatoid by Centre Hospitalier Universitaire de Saint Etienne — 2 open to participants now, 2 under way, none of them phase 3. Arthritis, Rheumatoid · Centre Hospitalier Universitaire de Saint Etienne.

Started
2026
the only one that year
No phase
5 of 11
1 open now
Registered
11th of 11
by date

Among the 11 studies in Arthritis, Rheumatoid by Centre Hospitalier Universitaire de Saint Etienne, this one is the only one that started in 2026, is one of 5 with no phase, and was the 11th registered.

Arthritis, Rheumatoid

3,339 studies on the registry are indexed under Arthritis, Rheumatoid; 446 are open to participants now.

Browse Arthritis, Rheumatoid studies →

Open to participants now

2 of the 11 studies in Arthritis, Rheumatoid by Centre Hospitalier Universitaire de Saint Etienne are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 2 open studies →

Where they have run

Who these studies take

Of the 293 Arthritis, Rheumatoid studies recruiting now, 151 (52%) set no upper age limit and 109 (37%) stop at 75 or younger; 15 take children under 18; 36 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 11 studies in Arthritis, Rheumatoid by Centre Hospitalier Universitaire de Saint Etienne, or all of them as a file.
02

Study summary

Rheumatoid arthritis affects 0.5% of the population, often leading to foot deformities and pain that are difficult to treat. Management is based on controlling inflammation, adapting footwear and using custom-made insoles, all of which have proven effective. The aim of this research is to build a digital model of plantar pressures based on CT scans, in order to optimize orthopedic insoles. The study will analyze the gait of patients with and without standard insoles to identify mechanical criteria correlated with pain. The ultimate aim is to design optimized insoles, validated by a new gait analysis.

03

Conditions studied

  • Rhumatoid Arthisis

Keywords

  • Insole
  • Rheumatoid arthritis
  • Feet
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Patients with rheumatoid arthritis according to 2010 ACR/EULAR criteria
  • RA at low activity level according to DAS28≤3.2
  • Patient with mechanical forefoot involvement on walking and improved by foot orthoses.

Exclusion criteria

Exclusion Criteria:

  • Patients with a to a bone scan
  • Patients with neurological gait disorders that interfere with gait analysis
  • Exclude particularly protected persons:

    • Pregnant women, parturients, nursing mothers;
    • Persons deprived of liberty, hospitalized without consent, hospitalized for purposes other than research;
    • Minors;
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
10 participants (estimated)

Study arms

  • Other
    3D imaging (foot CT scan)

    foot CT scan

    Other: gait analysis from 3D imaging (ENSENSO)

Interventions

  • Othergait analysis from 3D imaging (ENSENSO)

    gait analysis from 3D imaging (ENSENSO) on patients with bone geomtry 3D imaging

06

What researchers measure

Primary outcomes

  1. Construction of a patient-specific 3D model reproducing a gait cycle with or without an orthosis.

    Bone geometry from 3D imaging (foot CT) combined with gait analysis (speed, step length, angular variation at the knee and ankle) from 3D imaging (ENSENSO) and accelerometers

    Time frame: Week 1

Secondary outcomes

  1. Correlation of model parameters with pain

    \- Visual analogue scale (VAS) for pain in the right and left foot (0 = no pain; 10 = worst imaginable pain).

    Time frame: Day 1

  2. Correlation of model parameters with insole-wearing comfort.

    Visual analogue scale (VAS) for comfort in the right and left foot (0 = most comfortable; 10 = most uncomfortable).

    Time frame: Day 1

07

Study locations

1 of 1 sites recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jun 2026 (actual). Primary completion is estimated for Nov 2026, 5 months after the start.

Of 293 non-industry interventional studies with no phase under Arthritis, Rheumatoid, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 39. This study's planned 5 months is below that.

Counting every sponsor, half of 349 studies reached it within 27 months; a quarter within 13 and three quarters within 47.

How these figures are worked out, and which studies are left out of them.

Registered
Dec 22, 2025
First posted
Jan 7, 2026
StartActual
Jun 2, 2026
Primary completionEst.
Nov 2026
CompletionEst.
Dec 2026
Last update
Jun 5, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 5, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT07321340
Collaborators
SAINBIOSE
Responsible party
Sponsor
First posted
Jan 7, 2026
Start date
Jun 2, 2026
Primary completion
Nov 2026 (estimated)
Completion
Dec 2026 (estimated)
Last update
Jun 5, 2026

Study contacts

Hubert MAROTTE, MD PhD
Contact
hubert.marotte@chu-st-etienne.fr
(0)4 77 12 76 49 ext. +33
Florence RANCON, CDP
Contact
florence.rancon@chu-st-etienne.fr
(0)477829458 ext. +33

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion